Hengrui Pharma Begins Gauging Investor Interest for HK Listing

Jiangsu Hengrui Pharmaceuticals Co.began gauging investor interest on Tuesday for its planned Hong Kong listing.

The pre-deal investor education meetings will run until Friday and the listing date will be determined later, according to terms of the deal seen by Bloomberg News. The move comes after it won approval from the Hong Kong stock exchange to list its shares.

The Shanghai-listed firm plans to issue up to 815 million shares in Hong Kong, Hengrui said in a filing last month, after getting the green light from China’s securities regulator for its Hong Kong debut. The sale, likely worth at ...